Straumann Holding AG Change in Accounts Receivable 2012-2024 | SAUHY

Straumann Holding AG annual/quarterly change in accounts receivable history and growth rate from 2012 to 2024. Change in accounts receivable can be defined as the increase or decrease in accounts receivable for the given period.
  • Straumann Holding AG change in accounts receivable for the quarter ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • Straumann Holding AG change in accounts receivable for the twelve months ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • Straumann Holding AG annual change in accounts receivable for 2024 was $-0.138B, a 62.47% increase from 2023.
  • Straumann Holding AG annual change in accounts receivable for 2023 was $-0.085B, a 53.75% decline from 2022.
  • Straumann Holding AG annual change in accounts receivable for 2022 was $-0.183B, a 59.94% increase from 2021.
Straumann Holding AG Annual Change in Accounts Receivable
(Millions of US $)
2024 $-138
2023 $-85
2022 $-183
2021 $-114
2020 $57
2019 $-80
2018 $-61
2017 $-48
2016 $-34
2015 $7
2014 $-17
2013 $N/A
2012 $N/A
2011 $N/A
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $18.832B $2.845B
The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $84.708B 20.34
Becton Dickinson (BDX) United States $54.818B 13.40
Cardinal Health (CAH) United States $35.702B 18.14
West Pharmaceutical Services (WST) United States $17.650B 35.27
Cooper (COO) United States $12.915B 16.07
Align Technology (ALGN) United States $10.230B 20.16
Henry Schein (HSIC) United States $8.371B 14.81
Merit Medical Systems (MMSI) United States $5.333B 25.73
DENTSPLY SIRONA (XRAY) United States $2.857B 8.37
CONMED (CNMD) United States $1.663B 11.97
STAAR Surgical (STAA) United States $1.358B 0.00
Lifevantage (LFVN) United States $0.165B 17.01
Pro-Dex (PDEX) United States $0.151B 16.59